サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1773211

乳房挙上術の世界市場の評価：製品別、技法別、エンドユーザー別、地域別、機会、予測（2018年～2032年）

Mastopexy Market Assessment, By Product, By Technique, By End-user, By Region, Opportunities and Forecast, 2018-2032F

出版日
ページ情報
英文 243 Pages
納期
3～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.53円
乳房挙上術の世界市場の評価：製品別、技法別、エンドユーザー別、地域別、機会、予測（2018年～2032年）
出版日: 2025年07月21日
発行: Markets & Data
ページ情報: 英文 243 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の乳房挙上術の市場規模は、2024年の25億2,000万米ドルから2032年に40億5,000万米ドルに達すると予測され、予測期間の2025年～2032年にCAGRで6.13%の成長が見込まれます。ボディコントゥアリングや老化症状の治療に美容治療を求める人が増える中、市場は大幅な成長を示しています。マストペクシーと呼ばれる乳房挙上術は、自然な加齢、妊娠、授乳、大幅な体重減少によって下垂した乳房を持ち上げ、形を整える役割を果たします。ソーシャルメディアの影響力は、美の基準の変化とともに、特に30～50歳の女性を中心に、乳房挙上術を選択する人を増やしています。

市場は、安全性と結果を向上させる先進のインプラント技術や回復期間の短縮とともに、低侵襲手術を含む手術技法の向上から好影響を受けています。北米では、多額の医療費と熟練した美容外科医が多数存在し、年間手術件数も多いため、市場はその地位を維持しています。アジア太平洋は、可処分所得の増加や医療施設へのアクセス向上とともにメディカルツーリズムが伸びているため、市場拡大をもっとも速く主導するとみられます。

乳房挙上術と豊胸術を含む複合手技の人気は、カスタマイズされたソリューションの利用可能性とともに、市場のさらなる患者獲得に寄与しています。乳房挙上術市場は今後数年間、これらの市場促進要因によって継続的に拡大する可能性が高いです。

例えば2025年2月、Establishment Labs Holdings Inc.は、乳房美容と再建術を通じて女性のヘルス・ウェルネスを高めることに注力する世界の医療技術企業として活動しています。同社はブラジルでPreserveを正式に導入し、世界的な製品展開の初期段階を迎えました。当社は、Establishment LabsのMia Femtechの開発を継続し、Preserveと名付けられた低侵襲プラットフォームを通じて同社の第2の製品を発表しました。

当レポートでは、世界の乳房挙上術市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢などを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 米国関税の影響

第4章 エグゼクティブサマリー

第5章 世界の乳房挙上術市場の見通し（2018年～2032年）

  • 市場規模の分析と予測
    • 金額
  • 市場シェアの分析と予測
    • 製品別
      • 乳房インプラント
      • 手術器具
      • エネルギーベースデバイス
      • その他
    • 技法別
      • アンカー乳房挙上術
      • 三日月状乳房挙上術
      • 垂直乳房挙上術
      • その他
    • エンドユーザー別
      • 病院
      • 美容クリニック
      • その他
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋
      • 南米
      • 中東・アフリカ
    • 市場シェア分析：企業別（上位5社とその他）（金額）（2024年）
  • 市場マップ分析（2024年）
    • 製品別
    • 技法別
    • エンドユーザー別
    • 地域別

第6章 北米の乳房挙上術市場の見通し（2018年～2032年）

  • 市場規模の分析と予測
    • 金額
  • 市場シェアの分析と予測
    • 製品別
      • 乳房インプラント
      • 手術器具
      • エネルギーベースデバイス
      • その他
    • 技法別
      • アンカー乳房挙上術
      • 三日月形乳房挙上術
      • 垂直乳房挙上術
      • その他
    • エンドユーザー別
      • 病院
      • 美容クリニック
      • その他
    • シェア：国別
      • 米国
      • カナダ
      • メキシコ
  • 各国の市場の評価
    • 米国の乳房挙上術市場の見通し（2018年～2032年）
      • 市場規模の分析と予測
      • 市場シェアの分析と予測
    • カナダ
    • メキシコ

第7章 欧州の乳房挙上術市場の見通し（2018年～2032年）

  • ドイツ
  • フランス
  • イタリア
  • 英国
  • ロシア
  • オランダ
  • スペイン
  • トルコ
  • ポーランド

第8章 アジア太平洋の乳房挙上術市場の見通し（2018年～2032年）

  • インド
  • 中国
  • 日本
  • オーストラリア
  • ベトナム
  • 韓国
  • インドネシア
  • フィリピン

第9章 南米の乳房挙上術市場の見通し（2018年～2032年）

  • ブラジル
  • アルゼンチン

第10章 中東・アフリカの乳房挙上術市場の見通し（2018年～2032年）

  • サウジアラビア
  • アラブ首長国連邦
  • 南アフリカ

第11章 需給の分析

第12章 ポーターのファイブフォース分析

第13章 PESTLE分析

第14章 価格分析

第15章 市場力学

  • 市場促進要因
  • 市場の課題

第16章 市場動向と発展

第17章 政策と規制情勢

第18章 ケーススタディ

第19章 競合情勢

  • マーケットリーダー上位5社の競合マトリクス
  • 上位5社のSWOT分析
  • 主要企業上位10社の情勢
    • Allergan Plc (Abbvie Inc.)
    • GC Aesthetics Plc
    • Mentor Worldwide LLC (Johnson & Johnson)
    • Groupe Sebbin SAS
    • Sientra Inc.
    • Establishment Labs S.A.
    • Shanghai Kangning Medical Supplies Ltd.
    • Polytech Health & Aesthetics GmbH
    • HansBiomed Co. Ltd.
    • Silimed Industria de Implantes LTDA

第20章 戦略的提言

第21章 調査会社について・免責事項

図表

List of Tables

  • Table 1. Competition Matrix of Top 5 Market Leaders
  • Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. Global Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 3. Global Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 4. Global Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 5. Global Mastopexy Market Share (%), By Region, 2018-2032F
  • Figure 6. North America Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 7. North America Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 8. North America Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 9. North America Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 10. North America Mastopexy Market Share (%), By Country, 2018-2032F
  • Figure 11. United States Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 12. United States Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 13. United States Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 14. United States Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 15. Canada Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 16. Canada Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 17. Canada Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 18. Canada Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 19. Mexico Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 20. Mexico Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 21. Mexico Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 22. Mexico Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 23. Europe Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 24. Europe Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 25. Europe Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 26. Europe Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 27. Europe Mastopexy Market Share (%), By Country, 2018-2032F
  • Figure 28. Germany Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 29. Germany Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 30. Germany Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 31. Germany Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 32. France Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 33. France Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 34. France Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 35. France Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 36. Italy Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 37. Italy Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 38. Italy Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 39. Italy Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 40. United Kingdom Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 41. United Kingdom Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 42. United Kingdom Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 43. United Kingdom Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 44. Russia Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 45. Russia Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 46. Russia Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 47. Russia Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 48. Netherlands Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 49. Netherlands Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 50. Netherlands Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 51. Netherlands Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 52. Spain Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 53. Spain Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 54. Spain Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 55. Spain Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 56. Turkey Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 57. Turkey Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 58. Turkey Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 59. Turkey Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 60. Poland Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 61. Poland Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 62. Poland Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 63. Poland Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 64. South America Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 65. South America Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 66. South America Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 67. South America Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 68. South America Mastopexy Market Share (%), By Country, 2018-2032F
  • Figure 69. Brazil Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 70. Brazil Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 71. Brazil Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 72. Brazil Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 73. Argentina Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 74. Argentina Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 75. Argentina Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 76. Argentina Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 77. Asia-Pacific Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 78. Asia-Pacific Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 79. Asia-Pacific Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 80. Asia-Pacific Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 81. Asia-Pacific Mastopexy Market Share (%), By Country, 2018-2032F
  • Figure 82. India Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 83. India Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 84. India Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 85. India Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 86. China Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 87. China Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 88. China Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 89. China Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 90. Japan Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 91. Japan Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 92. Japan Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 93. Japan Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 94. Australia Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 95. Australia Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 96. Australia Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 97. Australia Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 98. Vietnam Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 99. Vietnam Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 100. Vietnam Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 101. Vietnam Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 102. South Korea Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 103. South Korea Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 104. South Korea Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 105. South Korea Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 106. Indonesia Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 107. Indonesia Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 108. Indonesia Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 109. Indonesia Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 110. Philippines Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 111. Philippines Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 112. Philippines Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 113. Philippines Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 114. Middle East & Africa Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 115. Middle East & Africa Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 116. Middle East & Africa Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 117. Middle East & Africa Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 118. Middle East & Africa Mastopexy Market Share (%), By Country, 2018-2032F
  • Figure 119. Saudi Arabia Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 120. Saudi Arabia Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 121. Saudi Arabia Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 122. Saudi Arabia Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 123. UAE Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 124. UAE Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 125. UAE Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 126. UAE Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 127. South Africa Mastopexy Market, By Value, In USD Billion, 2018-2032F
  • Figure 128. South Africa Mastopexy Market Share (%), By Product, 2018-2032F
  • Figure 129. South Africa Mastopexy Market Share (%), By Technique, 2018-2032F
  • Figure 130. South Africa Mastopexy Market Share (%), By End-user, 2018-2032F
  • Figure 131. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 132. By Technique Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 133. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 134. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024
目次
Product Code: MX13698

Global mastopexy market is projected to witness a CAGR of 6.13% during the forecast period 2025-2032, growing from USD 2.52 billion in 2024 to USD 4.05 billion in 2032. The global market for mastopexy is experiencing substantial growth as more people seek aesthetic treatments for body contouring and the treatment of aging symptoms. A breast lift operation called mastopexy serves to elevate and reshape drooping breasts, which results from natural aging, pregnancy, breastfeeding, and significant weight loss. Social media influence, alongside changing beauty standards, drives increasing numbers of people, particularly women between 30 to 50 years old, to select breast lift surgeries.

The market receives positive effects from surgical technique improvement, which include minimally invasive procedures alongside advanced implant technologies and faster recovery periods that improve safety and results. The market holds its position in North America because of substantial healthcare expenditures and numerous skilled cosmetic surgeons, together with a high number of annual procedures. The Asia-Pacific region will lead market expansion at the fastest rate because medical tourism grows alongside rising disposable income and improved access to aesthetic healthcare facilities.

The popularity of combination procedures, including mastopexy with augmentation, together with customized solution availability, helps the market reach additional patients. The mastopexy market shows strong potential for continued expansion throughout the upcoming years because of these market drivers.

For instance, in February 2025, Establishment Labs Holdings Inc. operates as a worldwide medical technology company that focuses on enhancing women's health and wellness through breast aesthetics and reconstruction procedures. The company officially introduced Preserve in Brazil, which marks the initial phase of its worldwide product expansion. The Company introduced its second product through the minimally invasive platform named Preserve, which continues the development of Mia Femtech by Establishment Labs.

Aesthetic and Anti-aging Trends Boost Global Mastopexy Market Demand

The global demand for mastopexy procedures experiences substantial growth because of aesthetic and anti-aging trends. The growing societal interest in youthful appearance, together with body image concerns, leads many individuals, primarily females, to undergo cosmetic surgery for physical aesthetic improvements. Breast lift surgery or mastopexy provides treatment for drooping breasts which occur from aging, weight fluctuations, and pregnancy effects, to restore youthful breast contours. Social media platforms joined with celebrity culture and beauty influences have normalized cosmetic procedures, which have increased public knowledge and acceptance. Growing aging population with rising disposable income chooses to spend money on procedures that eliminate visible aging signs. Mastopexy has become more attractive to potential patients because of the changing patient demographics and improved surgical methods, which require fewer incisions and shorter healing periods. The marketing approach from clinics positions these procedures within anti-aging packages to drive higher patient interest. Mastopexy procedures continue to experience steady growth because of current aesthetic trends and anti-aging developments.

Additionally, to maintain the trend, companies are collaborating despite advancements in breast cancer research and treatment. For instance, in October 2024, Galderma confirmed its ongoing partnership with the National Breast Cancer Foundation (NBCF) to support breast cancer survivors. The partnership continues its work to support individuals affected by breast cancer by providing services that enable survival and thriving. The partnership works to provide cutting-edge aesthetic solutions that enable individuals to rebuild their confidence and experience life with fresh energy.

Advancements in Surgical Techniques Fuel Market Growth

The mastopexy market benefits from surgical technique innovations, which drive its growth through better results alongside lower risk factors, and enhanced patient satisfaction. The current mastopexy operations rely on minimal surgical techniques alongside better incision designs and enhanced suturing systems to produce natural results which decrease scar visibility. Patients show rising interest in three main mastopexy market developments, which include laser-assisted lifts and 3D imaging pre-surgical planning, as well as combination procedures with mastopexy and augmentation. Internal bra techniques together with absorbable mesh implants offer extended duration of results, which minimizes the requirement for revision surgeries. The latest developments in mastopexy procedures have shortened recovery durations and reduced medical complications while improving operational effectiveness, which draws more patients and surgeons to choose this procedure. Clinics and manufacturers direct their investments toward new technologies because aesthetic standards continue to evolve while patients seek customized, safe effective procedures. These advancements serve as essential drivers for the rapid global expansion of the mastopexy market.

For instance, in September 2024, POLYTECH Health & Aesthetics GmbH introduced Opticon Plus as its newest product in its extensive product range. The new implant from POLYTECH extends their comprehensive product line by bridging the space between Replicon and Opticon anatomical forms. Surgeons now have access to Opticon Plus, which provides a base design that stands between the round Replicon base and the standard Opticon short oval base.

Breast Implants Hold the Largest Global Mastopexy Market Share

Breast implants maintain the highest market share within the mastopexy industry because patients increasingly choose dual procedures that address volume enhancement and breast position improvement. Patients who select breast lifts simultaneously pursue enhanced breast volume and youthful contours which implants deliver successfully. The combination of mastopexy with augmentation has gained popularity because it provides enduring aesthetic results that attract women who experience volume loss from aging and pregnancy and weight loss. The development of safer materials and diverse implant shapes and sizes, alongside more realistic outcomes, has boosted consumer confidence about implant technology. Plastic surgeons recommend implants during mastopexy procedures to achieve better symmetry and firmness which leads to more patients choosing this option. Beauty standards and customizable implant options together drive the preference for breast implants which maintain their position as the leading choice in the global mastopexy market.

For instance, in December 2024, Mentor Worldwide LLC, a part of Johnson & Johnson MedTech, revealed that the U.S. Food and Drug Administration (FDA) approved MENTOR MemoryGel Enhance Breast Implants for use in both primary and revision post-mastectomy breast reconstruction operations. The innovative silicone gel-filled implant collection provides an expanded selection of base widths together with new projections and volumes that extend to 930 cc through 1445 cc, the highest volume available in the market. The commercial debut of MemoryGel Enhance Breast Implants by Mentor occurs in the United States starting from mid-2025.

North America Dominates the Global Mastopexy Market Size

North America dominates the global mastopexy market due to several key factors such as high healthcare budgets, modern medical facilities, and a developed, strong public interest in cosmetic treatments. Aesthetic surgery rates in the United States rank among the highest worldwide because many women select mastopexy for breast sagging repair, which results from aging and weight changes and pregnancy effects. Market expansion receives significant support from the availability of skilled plastic surgeons and advanced surgical technologies, together with widespread public knowledge about aesthetic procedures. The market is expanding because of increasing disposable income levels and growing cultural support for cosmetic procedures. The region also gains from powerful social media trends and celebrity-driven beauty standards that motivate more people to pursue body contouring treatments. The rising focus on personal wellness and self-care practices has integrated mastopexy into broader anti-aging and lifestyle enhancement trends, which makes North America the leading market for this procedure.

Additionally, the rising cases of breast cancer support this region to grow in the mastopexy market. For instance, according to the American Cancer Society's estimates, about 316,950 new cases of invasive breast cancer will be diagnosed in women in 2025. Such growing cases increase the demand for mastopexy or breast lift surgery.

Impact of U.S. Tariffs on Global Mastopexy Market

U.S. tariffs have triggered substantial market shifts in mastopexy (breast lift) procedures because imported medical devices and materials have become more expensive. Surgical equipment, along with implants and related supplies, faces increased tariffs, which drive up prices for medical facilities and their patients, potentially leading to decreased demand. The rising costs might cause healthcare providers to explore domestic supply options or postpone non-urgent operations, thus affecting market growth rates. The increased expenses discourage businesses from launching operations in the aesthetic surgery market, which results in reduced innovation and fewer available services. The rising costs serve as a deterrent for patients who might otherwise undergo mastopexy treatments, which results in reduced procedure numbers. Domestic manufacturers experience an increased market share because consumers prefer local manufacturing products over imported materials. U.S. tariffs have generated financial uncertainties that affect pricing structures, as well as accessibility and market operations within the mastopexy industry.

Key Players Landscape and Outlook

The global mastopexy market competition involves major aesthetic corporations and clinical facilities that specialize in innovation alongside patient safety measures and satisfaction protocols. Main players direct their investments toward enhanced surgical procedures and implant technology alongside strategic alliances to broaden their worldwide presence. The market outlook remains optimistic because of increasing cosmetic treatment popularity, together with expanding medical tourism and shifting notions of beauty. The market will show consistent expansion while facing stronger competition due to ongoing technological progress throughout the next years.

In June 2023, the U.S. Food and Drug Administration (FDA) provided 510(k) clearance to Sientra, Inc. for its innovative AlloX2 Pro Tissue Expander. The AlloX2 Pro became the initial tissue expander in the United States to receive MRI-conditional approval, which permits its use during magnetic resonance imaging procedures needed by breast reconstruction patients.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. Global Mastopexy Market Outlook, 2018-2032F

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product
      • 5.2.1.1. Breast Implants
        • 5.2.1.1.1. Silicone Implants
        • 5.2.1.1.2. Saline Implants
        • 5.2.1.1.3. Cohesive Gel Implants
      • 5.2.1.2. Surgical Instruments
      • 5.2.1.3. Energy-based Devices
        • 5.2.1.3.1. Radiofrequency (RF) Devices
        • 5.2.1.3.2. High-Intensity Focused Ultrasound (HIFU)
        • 5.2.1.3.3. Laser-based Skin Tightening Equipment
      • 5.2.1.4. Others
    • 5.2.2. By Technique
      • 5.2.2.1. Anchor Mastopexy
      • 5.2.2.2. Crescent Mastopexy
      • 5.2.2.3. Vertical Mastopexy
      • 5.2.2.4. Others
    • 5.2.3. By End-user
      • 5.2.3.1. Hospitals
      • 5.2.3.2. Aesthetic and Cosmetology Clinics
      • 5.2.3.3. Others
    • 5.2.4. By Region
      • 5.2.4.1. North America
      • 5.2.4.2. Europe
      • 5.2.4.3. Asia-Pacific
      • 5.2.4.4. South America
      • 5.2.4.5. Middle East and Africa
    • 5.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 5.3. Market Map Analysis, 2024
    • 5.3.1. By Product
    • 5.3.2. By Technique
    • 5.3.3. By End-user
    • 5.3.4. By Region

6. North America Mastopexy Market Outlook, 2018-2032F

  • 6.1. Market Size Analysis & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share Analysis & Forecast
    • 6.2.1. By Product
      • 6.2.1.1. Breast Implants
        • 6.2.1.1.1. Silicone Implants
        • 6.2.1.1.2. Saline Implants
        • 6.2.1.1.3. Cohesive Gel Implants
      • 6.2.1.2. Surgical Instruments
      • 6.2.1.3. Energy-based Devices
        • 6.2.1.3.1. Radiofrequency (RF) Devices
        • 6.2.1.3.2. High-Intensity Focused Ultrasound (HIFU)
        • 6.2.1.3.3. Laser-based Skin Tightening Equipment
      • 6.2.1.4. Others
    • 6.2.2. By Technique
      • 6.2.2.1. Anchor Mastopexy
      • 6.2.2.2. Crescent Mastopexy
      • 6.2.2.3. Vertical Mastopexy
      • 6.2.2.4. Others
    • 6.2.3. By End-user
      • 6.2.3.1. Hospitals
      • 6.2.3.2. Aesthetic and Cosmetology Clinics
      • 6.2.3.3. Others
    • 6.2.4. By Country Share
      • 6.2.4.1. United States
      • 6.2.4.2. Canada
      • 6.2.4.3. Mexico
  • 6.3. Country Market Assessment
    • 6.3.1. United States Mastopexy Market Outlook, 2018-2032F*
      • 6.3.1.1. Market Size Analysis & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share Analysis & Forecast
        • 6.3.1.2.1. By Product
          • 6.3.1.2.1.1. Breast Implants
          • 6.3.1.2.1.1.1. Silicone Implants
          • 6.3.1.2.1.1.2. Saline Implants
          • 6.3.1.2.1.1.3. Cohesive Gel Implants
          • 6.3.1.2.1.2. Surgical Instruments
          • 6.3.1.2.1.3. Energy-based Devices
          • 6.3.1.2.1.3.1. Radiofrequency (RF) Devices
          • 6.3.1.2.1.3.2. High-Intensity Focused Ultrasound (HIFU)
          • 6.3.1.2.1.3.3. Laser-based Skin Tightening Equipment
          • 6.3.1.2.1.4. Others
        • 6.3.1.2.2. By Technique
          • 6.3.1.2.2.1. Anchor Mastopexy
          • 6.3.1.2.2.2. Crescent Mastopexy
          • 6.3.1.2.2.3. Vertical Mastopexy
          • 6.3.1.2.2.4. Others
        • 6.3.1.2.3. By End-user
          • 6.3.1.2.3.1. Hospitals
          • 6.3.1.2.3.2. Aesthetic and Cosmetology Clinics
          • 6.3.1.2.3.3. Others
    • 6.3.2. Canada
    • 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Mastopexy Market Outlook, 2018-2032F

  • 7.1. Germany
  • 7.2. France
  • 7.3. Italy
  • 7.4. United Kingdom
  • 7.5. Russia
  • 7.6. Netherlands
  • 7.7. Spain
  • 7.8. Turkey
  • 7.9. Poland

8. Asia-Pacific Mastopexy Market Outlook, 2018-2032F

  • 8.1. India
  • 8.2. China
  • 8.3. Japan
  • 8.4. Australia
  • 8.5. Vietnam
  • 8.6. South Korea
  • 8.7. Indonesia
  • 8.8. Philippines

9. South America Mastopexy Market Outlook, 2018-2032F

  • 9.1. Brazil
  • 9.2. Argentina

10. Middle East and Africa Mastopexy Market Outlook, 2018-2032F

  • 10.1. Saudi Arabia
  • 10.2. UAE
  • 10.3. South Africa

11. Demand Supply Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

  • 15.1. Market Drivers
  • 15.2. Market Challenges

16. Market Trends and Developments

17. Policy and Regulatory Landscape

18. Case Studies

19. Competitive Landscape

  • 19.1. Competition Matrix of Top 5 Market Leaders
  • 19.2. SWOT Analysis for Top 5 Players
  • 19.3. Key Players Landscape for Top 10 Market Players
    • 19.3.1. Allergan Plc (Abbvie Inc.)
      • 19.3.1.1. Company Details
      • 19.3.1.2. Key Management Personnel
      • 19.3.1.3. Products and Services
      • 19.3.1.4. Financials (As Reported)
      • 19.3.1.5. Key Market Focus and Geographical Presence
      • 19.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 19.3.2. GC Aesthetics Plc
    • 19.3.3. Mentor Worldwide LLC (Johnson & Johnson)
    • 19.3.4. Groupe Sebbin SAS
    • 19.3.5. Sientra Inc.
    • 19.3.6. Establishment Labs S.A.
    • 19.3.7. Shanghai Kangning Medical Supplies Ltd.
    • 19.3.8. Polytech Health & Aesthetics GmbH
    • 19.3.9. HansBiomed Co. Ltd.
    • 19.3.10. Silimed Industria de Implantes LTDA

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

20. Strategic Recommendations

21. About Us and Disclaimer